Abstract
Diabetes is a major public health problem currently affecting 382 million people across the world. A synthetic insulin delivery system that mimics the function of insulin-secreting cells and continuously releases insulin in response to blood glucose level changes holds great promise in improving the quality of life for diabetics. Here we report a new glucose-responsive formulation for self-regulated delivery of insulin using injectable hyaluronic acid (HA) microgels (µHA, average diameter: 5.9 ± 2.3 µm) integrated with acid-degradable ketal-modified dextran-based glucose responsive nanoparticles (GRN, average diameter: 226.9 ± 20.6 nm). Packed with insulin and a glucose-specific enzyme (glucose oxidase, GOx) by a double-emulsion method, the dextran nanoparticles can be dissolved and subsequently release insulin in a hyperglycemic state, triggered by the enzymatic conversion of glucose into gluconic acid. To further avoid the burst release, reduce loss of enzymes, and facilitate administration, we integrated nanoparticles into HA microgels, crosslinked through an emulsion procedure. In vitro studies demonstrated that the insulin release rate associated with HA microgels was effectively regulated by changes in the glucose concentration. In vivo studies, in which chemically-induced type 1 diabetic mice were subcutaneously injected with the microgels, validated that a single injection of the developed formulation stabilized the blood glucose levels in the normoglycemic state (<200 mg/dL) for over 1 week.
Similar content being viewed by others
References
Bachelder, E. M., T. T. Beaudette, K. E. Broaders, J. Dashe, and J. M. Fréchet. Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications. J. Am. Chem. Soc. 130:10494–10495, 2008.
Bratlie, K. M., R. L. York, M. A. Invernale, R. Langer, and D. G. Anderson. Materials for diabetes therapeutics. Adv. Healthc. Mater. 1:267–284, 2012.
Chauhan V. P., J. D. Martin, H. Liu, D. A. Lacorre, S. R. Jain, S. V. Kozin, T. Stylianopoulos, A. S. Mousa, X. Han, P. Adstamongkonkul, Z. Popovic, P. Huang, M. G. Bawendi, Y. Boucher, and R. K. Jain. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat. Commun. 4, 2013.
DiSanto, R. M., V. Subramanian, and Z. Gu. Recent Advances in Nanotechnology for Diabetes Treatment. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2015.
Gordijo, C. R., A. J. Shuhendler, and X. Y. Wu. Glucose-responsive bioinorganic nanohybrid membrane for self-regulated insulin release. Adv. Funct. Mater. 20:1404–1412, 2010.
Gu, Z., A. A. Aimetti, Q. Wang, T. T. Dang, Y. Zhang, O. Veiseh, H. Cheng, R. S. Langer, and D. G. Anderson. Injectable nano-network for glucose-mediated insulin delivery. ACS Nano 7:4194–4201, 2013.
Gu, Z., T. T. Dang, M. Ma, B. C. Tang, H. Cheng, S. Jiang, Y. Dong, Y. Zhang, and D. G. Anderson. Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery. ACS Nano 7:6758–6766, 2013.
Khetan, S., M. Guvendiren, W. R. Legant, D. M. Cohen, C. S. Chen, and J. A. Burdick. Degradation-mediated cellular traction directs stem cell fate in covalently crosslinked three-dimensional hydrogels. Nat. Mater. 12:458–465, 2013.
Kim, H., Y. J. Kang, S. Kang, and K. T. Kim. Monosaccharide-responsive release of insulin from polymersomes of polyboroxole block copolymers at neutral pH. J. Am. Chem. Soc. 134:4030–4033, 2012.
Miyake, K., T. Tanaka, and P. L. McNeil. Lectin-based food poisoning: a new mechanism of protein toxicity. PLoS ONE 2:e687, 2007.
Mo, R., T. Jiang, J. Di, W. Tai, and Z. Gu. Emerging micro-and nanotechnology based synthetic approaches for insulin delivery. Chem. Soc. Rev. 43:3595–3629, 2014.
Murthy, N., M. Xu, S. Schuck, J. Kunisawa, N. Shastri, and J. M. Fréchet. A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels. Proc. Natl. Acad. Sci. 100:4995–5000, 2003.
Owens, D. R., B. Zinman, and G. B. Bolli. Insulins today and beyond. Lancet 358:739–746, 2001.
Pickup, J. C., Z.-L. Zhi, F. Khan, T. Saxl, and D. J. S. Birch. Nanomedicine and its potential in diabetes research and practice. Diabetes-Metab. Res. Rev. 24:604–610, 2008.
Podual, K., F. Doyle, and N. Peppas. Preparation and dynamic response of cationic copolymer hydrogels containing glucose oxidase. Polymer 41:3975–3983, 2000.
Podual, K., F. J. Doyle, and N. A. Peppas. Glucose-sensitivity of glucose oxidase-containing cationic copolymer hydrogels having poly (ethylene glycol) grafts. J. Controlled Release 67:9–17, 2000.
Ravaine, V., C. Ancla, and B. Catargi. Chemically controlled closed-loop insulin delivery. J. Controlled Release 132:2–11, 2008.
Tabák, A. G., C. Herder, W. Rathmann, E. J. Brunner, and M. Kivimäki. Prediabetes: a high-risk state for diabetes development. Lancet 379:2279–2290, 2012.
Tai, W., R. Mo, J. Di, V. Subramanian, X. Gu, J. B. Buse, and Z. Gu. Bio-inspired synthetic nanovesicles for glucose-responsive release of insulin. Biomacromolecules 15:3495–3502, 2014.
Taylor, M. J., S. Tanna, and T. Sahota. In vivo study of a polymeric glucose-sensitive insulin delivery system using a rat model. J. Pharm. Sci. 99:4215–4227, 2010.
Vaz, A. F., M. P. Souza, L. D. Vieira, J. S. Aguiar, T. G. Silva, P. L. Medeiros, A. M. Melo, R. A. Silva-Lucca, L. A. Santana, and M. L. Oliva. High doses of gamma radiation suppress allergic effect induced by food lectin. Radiat. Phys. Chem. 85:218–226, 2013.
Veiseh, O., B. C. Tang, K. A. Whitehead, D. G. Anderson, and R. Langer. Managing diabetes with nanomedicine: challenges and opportunities. Nat. Rev. Drug Discov. 14:45–57, 2015.
Wu, Q., L. Wang, H. Yu, J. Wang, and Z. Chen. Organization of glucose-responsive systems and their properties. Chem. Rev. 111:7855–7875, 2011.
Yin, R., Z. Tong, D. Yang, and J. Nie. Glucose and pH dual-responsive concanavalin A based microhydrogels for insulin delivery. Int. J. Biol. Macromol. 49:1137–1142, 2011.
Yu, J.-C., Y.-L. Chen, Y.-Q. Zhang, X.-K. Yao, C.-G. Qian, J. Huang, S. Zhu, X.-Q. Jiang, Q.-D. Shen, and Z. Gu. pH-Responsive and near-infrared-emissive polymer nanoparticles for simultaneous delivery, release, and fluorescence tracking of doxorubicin in vivo. Chem. Commun. 50:4699–4702, 2014.
Zhang, Y., J. Yu, Q. Shen, and Z. Gu. Glucose-responsive synthetic closed-loop insulin delivery systems. Prog. Chem. 27:11–26, 2015.
Zhao, Y., B. G. Trewyn, I. I. Slowing, and V. S.-Y. Lin. Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP. J. Am. Chem. Soc. 131:8398–8400, 2009.
Zhao, W., H. Zhang, Q. He, Y. Li, J. Gu, L. Li, H. Li, and J. Shi. A glucose-responsive controlled release of insulin system based on enzyme multilayers-coated mesoporous silica particles. Chem. Commun. 47:9459–9461, 2011.
Acknowledgments
This work was supported by the grants from the American Diabetes Association (ADA) to Z.G. (1-14-JF-29 and 1-15-ACE-21) and the grant from NC TraCS, NIH’s Clinical and Translational Science Awards (CTSA, NIH grant 1UL1TR001111) at UNC-CH.
Conflict of interest
Jin Di, Jicheng Yu, Yanqi Ye, Davis Ranson, Abhilasha Jindal and Zhen Gu declare that they have no conflicts of interest.
Ethical Standards
No human studies were carried out by the authors for this article. All animal studies were carried out in accordance with institutional, national, international guidelines and approved by the Institutional Animal Care and Use Committee at North Carolina State University and University of North Carolina at Chapel Hill.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Nicholas Peppas oversaw the review of this article.
This article is part of the 2015 Young Innovators Issue.
Zhen Gu received his B.S. degree in Chemistry and M.S. degrees in Polymer Chemistry and Physics from Nanjing University. In 2010, he obtained Ph.D. degree at the University of California, Los Angeles, under the guidance of Prof. Yi Tang in the Department of Chemical and Biomolecular Engineering. He was a postdoctoral associate working with Prof. Robert Langer at Massachusetts Institute of Technology and Harvard Medical School during 2010 to 2012. He is currently an Assistant Professor in the Joint Department of Biomedical Engineering at the University of North Carolina at Chapel Hill and North Carolina State University. He also holds joint positions in the Molecular Pharmaceutics Division in the UNC Eshelman School of Pharmacy and Endocrinology and Metabolism Division in the Department of Medicine. His group studies controlled drug delivery, bio-inspired materials and nanobiotechnology. He has published over 50 research papers and applied 20 patents. He is the recipient of the Pathway Award and Junior Faculty Award of the American Diabetes Association and the Sigma Xi Young Faculty Research Award.
Jin Di and Jicheng Yu have contributed equally to the study.
Rights and permissions
About this article
Cite this article
Di, J., Yu, J., Ye, Y. et al. Engineering Synthetic Insulin-Secreting Cells Using Hyaluronic Acid Microgels Integrated with Glucose-Responsive Nanoparticles. Cel. Mol. Bioeng. 8, 445–454 (2015). https://doi.org/10.1007/s12195-015-0390-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12195-015-0390-y